Trial intelligence / Profile preview

Tranexamic acid oral solution for prevention of bleeding after tooth extraction in anticoagulated adults

2023-503719-13-00Phase 3Completed

Sponsor
Hyloris
Start
May 2024
Modality
Small Molecules
Countries
5
01

Overview

Phase 3, randomised, double-blind trial in postoperative oral hemorrhage comparing Tranexamic acid oral solution 5% with Matching placebo (2 arms). Primary endpoint: Number of clinically relevant postoperative oral bleeding episodes. Started May 2024; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative oral hemorrhage

Beyond the preview

Go deeper on 2023-503719-13-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-503719-13-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call